NuScale Power Corporation (SMR), a pioneer in small modular reactor (SMR) technology, stands at a pivotal juncture in the nuclear energy renaissance. As the only company to receive U.S. Nuclear Regulatory Commission (NRC) design certification for its VOYGR SMRs in 2020 and 2023, NuScale has positioned itself as a leader in scalable, carbon-free power solutions amid surging global demand for reliable energy, particularly from AI data centers and electrification trends. However, its financial trajectory reveals a classic pre-commercial innovator’s profile: explosive revenue growth forecasts juxtaposed against persistent losses, aggressive share dilution, and a wave of insider selling that warrants scrutiny. The stock’s volatility—from a 2023 low representing a steep plunge to a 2024 high surge of over 1,600% from that trough—mirrors broader sector hype around nuclear revival, yet recent trading levels suggest investor caution as fundamentals catch up.
Revenue Momentum and Operational Scaling
NuScale’s revenue has shown robust compounding, rising from $0.6 million in 2020 to $37.0 million in 2024, a staggering 6,075% increase over four years. This acceleration reflects commercialization efforts post-SPAC merger with Spring Valley Acquisition Corp in May 2022, which provided public market access and capital amid a nuclear sector thaw. Revenue per employee, a key efficiency metric for capital-intensive tech firms, climbed from $21,230 in 2022 to $112,258 in 2024 (429% growth), even as headcount trimmed from 556 to 330 (41% reduction), signaling leaner operations amid cost controls.
Looking ahead, analyst projections paint an even brighter picture: revenue forecasted at $40.4 million in 2025 (9% growth), exploding to $101.6 million in 2026 (152% year-over-year) and $248.4 million in 2027 (145% further). Revenue per share echoes this, leaping from $0.40 in 2024 to $0.88 in 2027 (121% cumulative). These figures are critical for SMR developers, where early revenue validates technology scalability—NuScale’s NRC approvals and partnerships like the 2024 Standard Power deal for 2 GW of SMR deployments underscore potential. Yet, this growth hinges on project wins; the 2023 cancellation of the Utah Associated Municipal Power Systems (UAMPS) project due to ballooning costs (from $5B to $9B) was a gut punch, eroding credibility and contributing to the stock’s 2023 low.
Gross margins offer a silver lining, surging to 86.7% in 2024 from 16.9% in 2023 (414% improvement). This metric is vital for hardware-heavy firms like NuScale, as it indicates improving manufacturing efficiencies and pricing power on reactor modules. Correlated with revenue per share trends, it suggests a path to profitability if scaled deployments materialize, buoyed by U.S. Department of Energy (DoE) funding awards totaling over $1B in recent years for SMR advancement.
Persistent Losses and Cash Burn Challenges
Despite topline promise, bottom-line woes persist. Earnings before tax (EBT) deteriorated to -$346.5 million in 2024 from -$180.1 million in 2023 (92% worsening), with EBT margin at -9.4%. Net income followed suit, hitting -$348.4 million in 2024 (94% decline from prior year). Earnings per share (EPS) plummeted to -$1.47, reflecting dilution’s bite. These red flags are par for nuclear startups—ROIC cratered to -13.4% in 2024, highlighting inefficient capital deployment in R&D and certification.
Cash flow paints a bleaker picture: operating cash flow at -$108.7 million in 2024, free cash flow per share at -$1.17. Cumulative free cash flow burn since 2020 exceeds $400 million, funded by equity raises that ballooned shares outstanding from 28.8 million in 2021 to 93.3 million in 2024 (224% increase), and a forecasted quadrupling to 282.8 million in 2025. This dilution crushes book value per share, flipping from $4.86 in 2024 to negative territory in 2025-2026. ROE at -46.9% in 2024 underscores equity erosion, a red flag for investors as it amplifies volatility in a hype-driven stock.
Projections brighten marginally: EBT improves to -$111.4 million in 2025 (68% less loss) and -$67.1 million in 2026 (40% further), with net income narrowing to -$67.4 million by 2027. EPS forecasts -2.20 in 2025 (worsening due to dilution) but rebounding to -$0.35 in 2027 (84% improvement). Paired with capex per share nearing zero, this hints at cash flow inflection if revenue ramps. However, EV/sales balloons to 84.9x in 2025 from 33.7x in 2024, pricing in aggressive growth but exposing frothiness.
| Key Metric | 2022 | 2023 | 2024 | 2025F | 2026F | 2027F |
|---|---|---|---|---|---|---|
| Revenue ($M) | 11.8 | 22.8 | 37.0 | 40.4 | 101.6 | 248.4 |
| Net Income ($M) | -141.6 | -180.1 | -348.4 | -363.5 | -136.5 | -67.4 |
| EPS | -0.55 | -0.80 | -1.47 | -2.20 | -0.57 | -0.35 |
| Gross Margin % | 38.0 | 16.9 | 86.7 | — | — | — |
| Shares (M) | 50.8 | 73.4 | 93.3 | 282.8 | 282.8 | 282.8 |
Stock Performance in Context
The stock’s journey correlates tightly with milestones and setbacks. Post-SPAC in 2022, it traded between levels implying a modest range (low near $9, high $16), buoyed by nuclear hype. 2023’s UAMPS flop triggered a collapse to a low around $2 (80% drop from 2022 high), with PS ratio contracting to 10.1x from 44.0x. Rebound ensued in 2024, spiking to a high over $32 (1,600% from 2023 low), fueled by AI-nuclear buzz, DoE grants, and gross margin jump—PS ratio expanded to 45.1x, PB to 3.7x.
Recent levels, post a 2024 peak, sit approximately 56% below that high but 690% above the 2023 trough. Valuation multiples like negative PE and elevated EV/sales reflect growth bets, but working capital ballooned to $381 million in 2024 (468% from 2023), bolstering liquidity amid net debt of -$447 million (cash rich). Yet, ROA at -35.5% lags peers, tying price swings to execution risks.
Insider Activity Signals Caution
Zero insider buys across 2025-2026 contrast sharply with prolific sells totaling dozens of transactions. March 2025 saw nine sells by executives (CEO, CFO, CTO, COO, etc.), followed by clusters in May (seven), September (four massive by a 10% director), and October (two more by the same). The director offloaded millions of shares in September-October, dwarfing executive volumes. Cumulative sell proceeds exceed $619 million, with no buys signaling alignment issues. In a nascent firm, insider selling—especially at highs—often precedes pullbacks, correlating here with post-2024 peak consolidation. This lacks counterbalance from purchases, amplifying downside risks.
Analyst Outlook and Future Catalysts
Analysts remain bullish, with price targets implying 5% upside at the low end, 64% at the mean, and 319% at the high from recent levels. This optimism tracks revenue hypergrowth and SMR tailwinds: global pledges for tripled nuclear capacity by 2050, U.S. Inflation Reduction Act credits, and hyperscaler deals (e.g., NuScale’s 2024 MOU with RoPower in Romania). Anticipated developments include first VOYGR deployments by 2029-2030, potential DoE loan guarantees, and partnerships amid Big Tech’s nuclear push (Microsoft-Constellation, Google-Kairos).
Risks loom: dilution could pressure EPS, project delays (echoing UAMPS) might stall revenue, and competition from TerraPower or X-energy intensifies. Breakeven by 2027-2028 seems plausible if margins hold, but cash burn demands flawless execution. For risk-tolerant investors, NuScale offers nuclear pure-play exposure; conservative ones may await profitability proof. Overall, the setup blends transformative potential with high-beta volatility—watch for commercial orders to ignite the next leg.
(Word count: 1,128)